Kidney cancer deaths show overall decrease in Europe

Apr 09, 2008

Overall deaths from kidney cancer have now fallen across Europe after peaking in the early 1990s, according to a detailed analysis of mortality rates for 32 countries published in the urology journal BJU International.

The review is based on official death records collated by the World Health Organization from 1984 to 2004.

Male deaths from kidney cancer showed an overall reduction of 13 per cent between 1992 and 2002 across the European Union and female deaths fell by 17 per cent during the same period.

Figures for the previous decade had shown a 17 per cent rise for men and an 11 per cent rise for women.

Women are significantly less likely to die of kidney cancer than men – between 2000 and 2004 the death rate was 1.8 per 100,000 people for women and 4.1 for men.

“It is clear from our study that death rates for kidney cancer peaked in the 1990s and are now showing an overall downward trend” say lead authors Professor Fabio Levi from the University of Lausanne, Switzerland, and Professor Carlo La Vecchia from the University of Milan, Italy.

“However we found wide variations between countries when it came to deaths from kidney cancer and incidence of the disease.”

The largest reductions in kidney cancer deaths between 1992 and 2002 were in Austria (down 33 per cent for men and 32 per cent for women) and Germany (down 31 per cent for both men and women).

When it came to incidence rates, the largest reductions for men between 1992 and 2002 were in Sweden (down 18 per cent) and Finland (down 11 per cent) and for women in Sweden (down 19 per cent) and Denmark (down 12 per cent).

“Our study confirms that overall kidney cancer rates declined in the 1990s and that these decreases have been larger in men, people who are middle-aged and in western European countries” says Professor Levi.

“The fall in male deaths is consistent with the links between tobacco usage and kidney cancer risk as men, particularly those from western Europe, are the group who have shown the most favourable changes in smoking habits over the last few decades.”

There are a number of factors that may play a role in reducing the incidence of kidney cancer and death rates from the disease.

“Dietary factors might also play some role” says Professor Levi. “Although their influence on kidney cancer remains unclear, some studies have shown that people who eat a diet rich in vegetables and fruit are less likely to develop the disease.

“Other factors could include reduced exposure to occupational carcinogens, although the risk of such carcinogens on kidney cancer remains unclear.”

The authors say that there may also be a link with better control of high blood pressure, a known risk factor for the disease, and better control of urinary tract infections.

“The current study quantifies recent reductions in kidney cancer deaths and, to a lesser degree, the incidence of the disease” concludes Professor Levi.

“But apart from the role played by reduced tobacco smoking in men, interpretation of these trends remains open to discussion.”

Source: Wiley

Explore further: Philippines boosts MERS monitoring after UAE nurse scare

add to favorites email to friend print save as pdf

Related Stories

Intel prepared for shifts in computing, new CEO says

Sep 11, 2013

Discounting critics who contend it is mired in the slowing personal-computer market, microchip giant Intel Corp. assured a gathering of industry experts Tuesday that it is well-positioned to profit from the fast-changing ...

Amgen posts higher 2Q sales, profit to beat views

Jul 27, 2012

(AP) — Amgen Inc.'s second-quarter net income rose 8 percent as the world's largest biotech company benefited from higher sales for its top-selling drugs and a gain from selling its share of an experimental medicine.

Game-changing microfluidics

Sep 29, 2011

The development of miniaturization strategies that integrate several laboratory functions on a single chip is benefiting many areas of biomedical research, making even complex experiments faster and cheaper ...

Bristol-Myers pitches its cancer medicine pipeline

Jun 06, 2011

(AP) -- Bristol-Myers Squibb Co. executives said Monday they have more than a half-dozen drugs in testing against different cancers and could get important data on them and possibly a couple of approvals this year.

Recommended for you

US orders farms to report pig virus infections

Apr 18, 2014

The U.S. government is starting a new program to help monitor and possibly control the spread of a virus that has killed millions of pigs since showing up in the country last year.

Foreigner dies of MERS in Saudi

Apr 18, 2014

A foreigner has died after she contracted MERS in the Saudi capital, the health ministry said on announced Friday, bringing the nationwide death toll to 73.

Vietnam battles fatal measles outbreak

Apr 18, 2014

Vietnam is scrambling to contain a deadly outbreak of measles that has killed more than 100 people, mostly young children, and infected thousands more this year, the government said Friday.

New clues on tissue scarring in scleroderma

Apr 18, 2014

A discovery by Northwestern Medicine scientists could lead to potential new treatments for breaking the cycle of tissue scarring in people with scleroderma.

User comments : 0

More news stories

Treating depression in Parkinson's patients

A group of scientists from the University of Kentucky College of Medicine and the Sanders-Brown Center on Aging has found interesting new information in a study on depression and neuropsychological function in Parkinson's ...

Airbnb rental site raises $450 mn

Online lodging listings website Airbnb inked a $450 million funding deal with investors led by TPG, a source close to the matter said Friday.

Health care site flagged in Heartbleed review

People with accounts on the enrollment website for President Barack Obama's signature health care law are being told to change their passwords following an administration-wide review of the government's vulnerability to the ...